158 related articles for article (PubMed ID: 22431448)
1. Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature.
Rychetnik L; McCaffery K; Morton R; Irwig L
Psychooncology; 2013 Apr; 22(4):721-36. PubMed ID: 22431448
[TBL] [Abstract][Full Text] [Related]
2. Follow-up of early stage melanoma: specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals.
Rychetnik L; McCaffery K; Morton RL; Thompson JF; Menzies SW; Irwig L
J Surg Oncol; 2013 Apr; 107(5):463-8. PubMed ID: 23090908
[TBL] [Abstract][Full Text] [Related]
3. Patients' perspectives of long-term follow-up for localised cutaneous melanoma.
Morton RL; Rychetnik L; McCaffery K; Thompson JF; Irwig L
Eur J Surg Oncol; 2013 Mar; 39(3):297-303. PubMed ID: 23287820
[TBL] [Abstract][Full Text] [Related]
4. The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
Damude S; Hoekstra-Weebers JE; Francken AB; Ter Meulen S; Bastiaannet E; Hoekstra HJ
Ann Surg Oncol; 2016 Sep; 23(9):2762-71. PubMed ID: 27194552
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.
Livingstone E; Krajewski C; Eigentler TK; Windemuth-Kieselbach C; Benson S; Elsenbruch S; Hauschild A; Rompel R; Meiss F; Mauerer A; Kähler KC; Dippel E; Möllenhoff K; Kilian K; Mohr P; Utikal J; Schadendorf D
Eur J Cancer; 2015 Mar; 51(5):653-67. PubMed ID: 25638778
[TBL] [Abstract][Full Text] [Related]
6. A Systematic Review on the Impact of Genetic Testing for Familial Melanoma II: Psychosocial Outcomes and Attitudes.
Primiero CA; Yanes T; Finnane A; Soyer HP; McInerney-Leo AM
Dermatology; 2021; 237(5):816-826. PubMed ID: 33508831
[TBL] [Abstract][Full Text] [Related]
7. Systematic review of psychosocial outcomes for patients with advanced melanoma.
Dunn J; Watson M; Aitken JF; Hyde MK
Psychooncology; 2017 Nov; 26(11):1722-1731. PubMed ID: 27696578
[TBL] [Abstract][Full Text] [Related]
8. Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.
Cromwell KD; Ross MI; Xing Y; Gershenwald JE; Royal RE; Lucci A; Lee JE; Cormier JN
Melanoma Res; 2012 Oct; 22(5):376-85. PubMed ID: 22914178
[TBL] [Abstract][Full Text] [Related]
9. Shared care in the follow-up of early-stage melanoma: a qualitative study of Australian melanoma clinicians' perspectives and models of care.
Rychetnik L; Morton RL; McCaffery K; Thompson JF; Menzies SW; Irwig L
BMC Health Serv Res; 2012 Dec; 12():468. PubMed ID: 23253951
[TBL] [Abstract][Full Text] [Related]
10. Patient Preferences for Follow-up After Recent Excision of a Localized Melanoma.
Lim WY; Morton RL; Turner RM; Jenkins MC; Guitera P; Irwig L; Webster AC; Dieng M; Saw RPM; Low D; Low C; Bell KJL
JAMA Dermatol; 2018 Apr; 154(4):420-427. PubMed ID: 29490373
[TBL] [Abstract][Full Text] [Related]
11. Supportive care needs, anxiety, depression and quality of life amongst newly diagnosed patients with localised invasive cutaneous melanoma in Queensland, Australia.
Beesley VL; Smithers BM; Khosrotehrani K; Khatun M; O'Rourke P; Hughes MC; Malt MK; Zonta MJ; Bayley GJ; Barbour AP; Brown LJ; D'Arcy J; Allan CP; Green AC
Psychooncology; 2015 Jul; 24(7):763-70. PubMed ID: 25355178
[TBL] [Abstract][Full Text] [Related]
12. GP-led melanoma follow-up: views and feelings of patient recipients.
Murchie P; Delaney EK; Campbell NC; Hannaford PC
Support Care Cancer; 2010 Feb; 18(2):225-33. PubMed ID: 19430819
[TBL] [Abstract][Full Text] [Related]
13. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.
Turner RM; Bell KJ; Morton RL; Hayen A; Francken AB; Howard K; Armstrong B; Thompson JF; Irwig L
J Clin Oncol; 2011 Dec; 29(35):4641-6. PubMed ID: 22067399
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review on the Impact of Genetic Testing for Familial Melanoma I: Primary and Secondary Preventative Behaviours.
Primiero CA; Yanes T; Finnane A; Soyer HP; McInerney-Leo AM
Dermatology; 2021; 237(5):806-815. PubMed ID: 33588421
[TBL] [Abstract][Full Text] [Related]
15. Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature.
Kasparian NA; McLoone JK; Butow PN
Arch Dermatol; 2009 Dec; 145(12):1415-27. PubMed ID: 20026852
[TBL] [Abstract][Full Text] [Related]
16. [Melanoma patients: psychosocial stress, coping with illness and social support. A systematic review].
Söllner W; Zschocke I; Augustin M
Psychother Psychosom Med Psychol; 1998; 48(9-10):338-48. PubMed ID: 9785963
[TBL] [Abstract][Full Text] [Related]
17. Psychological distress surrounding diagnosis of malignant and nonmalignant skin lesions at a pigmented lesion clinic.
Al-Shakhli H; Harcourt D; Kenealy J
J Plast Reconstr Aesthet Surg; 2006; 59(5):479-86. PubMed ID: 16749193
[TBL] [Abstract][Full Text] [Related]
18. A qualitative assessment of psychosocial impact, coping and adjustment in high-risk melanoma patients and caregivers.
Tan JD; Butow PN; Boyle FM; Saw RP; O'Reilly AJ
Melanoma Res; 2014 Jun; 24(3):252-60. PubMed ID: 24584097
[TBL] [Abstract][Full Text] [Related]
19. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
